Hunan Er Kang Pharmaceutical (300267) — Financial Flexibility Index
Hunan Er Kang Pharmaceutical (300267) has a Financial Flexibility Index of 0.45x as of June 2023. Free cash flow of CN¥220.23 Million (operating CF CN¥174.55 Million minus capex CN¥45.68 Million) represents 0% of total liabilities (CN¥490.30 Million). Check cash flow reinvestment rate of Hunan Er Kang Pharmaceutical to assess the company's total reinvestment commitment from operating cash flow.
Financial Flexibility Index
Free Cash Flow
Total Liabilities
Capital Expenditures
Hunan Er Kang Pharmaceutical Financial Flexibility Index (2008–2024)
Historical Financial Flexibility Index trend for Hunan Er Kang Pharmaceutical across 17 annual periods. For the full cash flow conversion analysis, see 300267 operating cash flow.
Annual Financial Flexibility Index for Hunan Er Kang Pharmaceutical (2008–2024)
Year-by-year free cash flow to debt coverage for Hunan Er Kang Pharmaceutical. Explore cash flow to debt ratio of Hunan Er Kang Pharmaceutical to assess how comfortably operating cash covers total debt obligations.
| Year | Flexibility Index | Free Cash Flow (CNY) | Operating CF | Total Liabilities | YoY Change |
|---|---|---|---|---|---|
| 2024 | 0.45x | CN¥362.29 Million | CN¥166.69 Million | CN¥797.54 Million | ▼ -21.4% |
| 2023 | 0.58x | CN¥386.61 Million | CN¥148.42 Million | CN¥669.05 Million | ▲ +2.3% |
| 2022 | 0.56x | CN¥454.51 Million | CN¥281.02 Million | CN¥804.57 Million | ▼ -28.7% |
| 2021 | 0.79x | CN¥442.02 Million | CN¥92.68 Million | CN¥558.28 Million | ▼ -24.0% |
| 2020 | 1.04x | CN¥784.42 Million | CN¥178.53 Million | CN¥753.22 Million | ▼ -54.9% |
| 2019 | 2.31x | CN¥810.03 Million | CN¥445.82 Million | CN¥350.72 Million | ▲ +328.6% |
| 2018 | 0.54x | CN¥220.62 Million | CN¥123.89 Million | CN¥409.39 Million | ▼ -82.5% |
| 2017 | 3.07x | CN¥948.03 Million | CN¥689.11 Million | CN¥308.37 Million | ▼ -23.0% |
| 2016 | 3.99x | CN¥1.63 Billion | CN¥486.50 Million | CN¥408.94 Million | ▲ +99.3% |
| 2015 | 2.00x | CN¥1.09 Billion | CN¥518.96 Million | CN¥544.10 Million | ▲ +54.6% |
| 2014 | 1.30x | CN¥702.81 Million | CN¥175.38 Million | CN¥542.64 Million | ▼ -61.3% |
| 2013 | 3.35x | CN¥378.20 Million | CN¥174.22 Million | CN¥113.01 Million | ▼ -22.2% |
| 2012 | 4.30x | CN¥315.31 Million | CN¥84.02 Million | CN¥73.32 Million | ▲ +137.0% |
| 2011 | 1.81x | CN¥119.59 Million | CN¥75.72 Million | CN¥65.90 Million | ▲ +101.1% |
| 2010 | 0.90x | CN¥107.52 Million | CN¥42.47 Million | CN¥119.15 Million | ▲ +129.2% |
| 2009 | 0.39x | CN¥29.82 Million | CN¥10.18 Million | CN¥75.72 Million | ▲ +82.2% |
| 2008 | 0.22x | CN¥12.83 Million | CN¥211.00K | CN¥59.37 Million | — |